Exenatide is a GLP-1 receptor agonist.

Prepare for the Glucose Management Test with interactive quizzes featuring multiple choice questions, hints, and detailed explanations. Boost your confidence and be exam-ready!

Multiple Choice

Exenatide is a GLP-1 receptor agonist.

Explanation:
Exenatide works by activating GLP-1 receptors, making it a GLP-1 receptor agonist. By binding to these receptors, it enhances glucose-dependent insulin secretion from pancreatic beta cells, helping to lower blood glucose when glucose levels are elevated. It also suppresses glucagon release, slows gastric emptying, and increases satiety, all of which help control postprandial glucose and support overall glycemic management. This receptor-specific action distinguishes it from other pathways, such as GIP receptors, which it does not predominantly target. So the statement that exenatide is a GLP-1 receptor agonist is correct.

Exenatide works by activating GLP-1 receptors, making it a GLP-1 receptor agonist. By binding to these receptors, it enhances glucose-dependent insulin secretion from pancreatic beta cells, helping to lower blood glucose when glucose levels are elevated. It also suppresses glucagon release, slows gastric emptying, and increases satiety, all of which help control postprandial glucose and support overall glycemic management. This receptor-specific action distinguishes it from other pathways, such as GIP receptors, which it does not predominantly target. So the statement that exenatide is a GLP-1 receptor agonist is correct.

More Multiple Choice Questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy